Preparation and in vitro/in vivo evaluation of azilsartan osmotic pump tablets based on the preformulation investigation

Abstract The objective of this study was to design and evaluate azilsartan osmotic pump tablets. Preformulation properties of azilsartan were investigated for formulation design. Azilsartan osmotic pump tablets were prepared by incorporation of drug in the core and subsequent coating with cellulose acetate and polyethylene glycol 4000 as semi-permeable membrane, then drilled an orifice at the center of one side. The influence of different cores, compositions of semipermeable membrane and orifice diameter on azilsartan release were evaluated. The formulation of core tablet was optimized by orthogonal design and the release profiles of various formulations were evaluated by similarity factor (f2). The optimal formulation achieved to deliver azilsartan at an approximate zero-order up to 14 h. The pharmacokinetic study was performed in beagle dogs. The azilsartan osmotic pump tablets exhibited less fluctuation in blood concentration and higher bioavailability compared to immediate-release tablets. Moreover, there was a good correlation between the in vitro dissolution and in vivo absorption of the tablets. In summary, azilsartan osmotic pump tablets presented controlled release in vitro, high bioavailability in vivo and a good in vitro-in vivo correlation.

[1]  G. Abdelbary,et al.  Zero-order release and bioavailability enhancement of poorly water soluble Vinpocetine from self-nanoemulsifying osmotic pump tablet , 2018, Pharmaceutical development and technology.

[2]  Haoyang Wen,et al.  In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants , 2018, Drug development and industrial pharmacy.

[3]  W. Pan,et al.  Design and Evaluation of Bilayer Pump Tablet of Flurbiprofen Solid Dispersion for Zero-Order Controlled Delivery. , 2017, Journal of pharmaceutical sciences.

[4]  W. Pan,et al.  Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery , 2017, Drug development and industrial pharmacy.

[5]  Alfonso T. Perez,et al.  Azilsartan in Patients With Mild to Moderate Hypertension Using Clinic and Ambulatory Blood Pressure Measurements , 2017, Journal of clinical hypertension.

[6]  Haoyang Wen,et al.  Aqueous Polymer Dispersion Coating Used for Osmotic Pump Tablets: Membrane Property Investigation and IVIVC Evaluation , 2017, AAPS PharmSciTech.

[7]  Youxin Li,et al.  Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant , 2016, Pharmaceutical development and technology.

[8]  Jiangnan Yu,et al.  Sustained-release of Cyclosporin A pellets: preparation, in vitro release, pharmacokinetic studies and in vitro–in vivo correlation in beagle dogs , 2016, Drug development and industrial pharmacy.

[9]  Wei Wu,et al.  Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology , 2016, Pharmaceutical Research.

[10]  Wang Junfeng,et al.  UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study , 2015 .

[11]  Meiyan Yang,et al.  Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system , 2015, Drug development and industrial pharmacy.

[12]  Zhihong Zhu,et al.  Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation. , 2014, International journal of pharmaceutics.

[13]  Wei He,et al.  Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. , 2014, International journal of pharmaceutics.

[14]  A. Rajabi-Siahboomi,et al.  Investigation of Critical Core Formulation and Process Parameters for Osmotic Pump Oral Drug Delivery , 2014, AAPS PharmSciTech.

[15]  Wei Wu,et al.  Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs. , 2013, International journal of pharmaceutics.

[16]  K. Adibkia,et al.  The Effect of Pore-Formers and Plasticizers on the Release Kinetic of Diltiazem Hydrochloride from the Controlled Porosity Osmotic Pumps , 2013, Drug Research.

[17]  G. Reboldi,et al.  Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension , 2013, Expert opinion on drug metabolism & toxicology.

[18]  Xing-gang Yang,et al.  In vitro and in vivo evaluation of gliclazide push–pull osmotic pump coated with aqueous colloidal polymer dispersions , 2013, Drug development and industrial pharmacy.

[19]  Mukesh R. Patel,et al.  Recent patent in controlled porosity osmotic pump. , 2012, Recent patents on drug delivery & formulation.

[20]  H. Rakugi,et al.  Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study , 2012, Hypertension Research.

[21]  Sum Lam.  Azilsartan: A Newly Approved Angiotensin II Receptor Blocker , 2011, Cardiology in review.

[22]  H. Kangas,et al.  Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  K. Kusumoto,et al.  In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies , 2011, Journal of Pharmacology and Experimental Therapeutics.

[24]  J. Qiu,et al.  Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. , 2011, International journal of pharmaceutics.

[25]  H. Leuenberger,et al.  Development of Push–Pull Osmotic Tablets Using Chitosan–Poly(Acrylic Acid) Interpolymer Complex as an Osmopolymer , 2011, AAPS PharmSciTech.

[26]  N. Narayanan,et al.  Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system. , 2010, International journal of pharmaceutics.

[27]  V. Stella,et al.  Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent. , 2009, Journal of pharmaceutical sciences.

[28]  B. Macdonald,et al.  Extrudable core system: development of a single-layer osmotic controlled-release tablet. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Ali Nokhodchi,et al.  Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  Dinesh Mishra,et al.  A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. , 2008, International journal of pharmaceutics.

[31]  M. Barzegar-Jalali,et al.  Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. , 2005, Journal of pharmaceutical and biomedical analysis.

[32]  Yi Tsong,et al.  In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2 , 1998, Pharmaceutical Research.

[33]  Hans Lennernäs,et al.  Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.

[34]  Sanjay Garg,et al.  Osmotic pumps in drug delivery. , 2004, Critical reviews in therapeutic drug carrier systems.

[35]  F Theeuwes,et al.  Elementary osmotic pump. , 1975, Journal of pharmaceutical sciences.